The FDA has approved a label expansion for once-weekly tirzepatide for adults with overweight and obesity, allowing the medication to be used with a pen that is equipped with four doses of the drug, ...
Phase III study will be "sufficient and pivotal for registration in the U.S." Kiniksa Pharmaceuticals ( KNSA 4.16%) ...
Fox News viewers are scrutinizing Press Secretary Karoline Leavitt after her visit to the network saw her throw inaccurate ...
Elizabeth City, NC - February 23, 2026 - RE+Vitalize Health and Nutrition, a retail health and nutrition brand based in ...
Donald Trump rarely hesitates to label other people and their ideas as “crazy,” despite a well-documented pattern of wandering monologues and off-the-rails asides of his […] ‘I Gave Her Money’: Trump’ ...
The popular class of weight loss drugs known as GLP-1s have shown to be effective in curbing cravings beyond food. A few early studies have suggested that GLP-1 medications can do a lot to alleviate ...
Operating capital runway sufficient into the fourth quarter of 2026 In-person Type C FDA meeting scheduled by end of the first quarter of 2026 to discuss the latest CNM-Au8 data submitted in late ...
Announced positive 12-week results from the 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ― ...
The 2026 British Academy Film Awards (BAFTAs) took place last night in London. Hosted by The Traitors star Alan Cumming, the ...